CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $490K of Corcept Therapeutics Incorporated
Sold$489,700
$48.97Price
10,000Shares
−63%Stake
What CORT did after the filing
- The stock from Wed, Nov 6 open, $54.08
- −5.4%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the Dec 19 close.
Traded Fri, Nov 1. Filed Tue, Nov 5, 7:48 PM ET, after the close. Returns use the Nov 6 open and the Dec 19 close. Not investment advice.